Header Logo

Mohit Chopra

Concepts (131)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cocaine-Related Disorders
4
2025
76
0.740
Why?
Stress Disorders, Post-Traumatic
3
2016
374
0.730
Why?
Depressive Disorder
3
2009
292
0.720
Why?
Opioid-Related Disorders
5
2025
470
0.610
Why?
Memantine
3
2014
23
0.590
Why?
Methadone
3
2025
130
0.590
Why?
Excitatory Amino Acid Antagonists
2
2013
31
0.490
Why?
Social Stigma
1
2016
67
0.490
Why?
Health Status
2
2016
451
0.490
Why?
Obsessive-Compulsive Disorder
1
2011
32
0.380
Why?
Patient Acceptance of Health Care
1
2016
455
0.370
Why?
Benzodiazepines
1
2011
99
0.370
Why?
Narcotics
2
2025
53
0.360
Why?
Alzheimer Disease
3
2014
560
0.350
Why?
Disulfiram
2
2025
5
0.340
Why?
Quality of Life
2
2016
1140
0.330
Why?
Apolipoprotein E4
1
2009
35
0.320
Why?
Depressive Disorder, Major
3
2011
261
0.320
Why?
Methadyl Acetate
1
2008
1
0.310
Why?
Reward
1
2009
83
0.310
Why?
Antipsychotic Agents
1
2011
311
0.310
Why?
Psychiatric Status Rating Scales
2
2013
386
0.310
Why?
Narcotic Antagonists
2
2014
116
0.300
Why?
Naloxone
1
2008
54
0.300
Why?
Buprenorphine
2
2014
189
0.280
Why?
Aging
1
2013
731
0.280
Why?
Cognition Disorders
1
2008
219
0.270
Why?
Alcohol Deterrents
1
2025
6
0.250
Why?
Dementia
1
2008
251
0.240
Why?
Geriatric Assessment
1
2006
165
0.240
Why?
Long-Term Care
1
2006
176
0.240
Why?
Aged
12
2016
13596
0.230
Why?
Male
19
2025
27951
0.230
Why?
Opiate Substitution Treatment
3
2025
196
0.220
Why?
Female
18
2025
31226
0.220
Why?
Hallucinations
1
2003
17
0.210
Why?
Vitamin E
2
2014
54
0.210
Why?
Depression
3
2016
868
0.210
Why?
Treatment Refusal
1
2003
59
0.210
Why?
Mental Competency
1
2003
63
0.200
Why?
Anxiety
3
2016
400
0.200
Why?
Comorbidity
3
2016
1099
0.200
Why?
Informed Consent
1
2003
133
0.190
Why?
Antioxidants
2
2014
248
0.190
Why?
Attitude to Health
1
2003
280
0.180
Why?
Humans
21
2025
60081
0.170
Why?
Nursing Homes
1
2006
672
0.170
Why?
Decision Making
1
2003
394
0.160
Why?
Double-Blind Method
6
2025
684
0.150
Why?
Severity of Illness Index
5
2014
1471
0.140
Why?
Veterans
3
2016
729
0.140
Why?
Dose-Response Relationship, Drug
3
2025
806
0.140
Why?
Cyclohexanecarboxylic Acids
1
2014
9
0.110
Why?
Dopamine Agents
1
2014
10
0.110
Why?
Amines
1
2014
30
0.110
Why?
Sertraline
1
2014
60
0.110
Why?
gamma-Aminobutyric Acid
1
2014
78
0.110
Why?
Aged, 80 and over
4
2014
5200
0.110
Why?
Alcohol-Related Disorders
1
2013
36
0.100
Why?
Adult
8
2025
15972
0.100
Why?
Alcoholism
1
2016
308
0.100
Why?
Longitudinal Studies
2
2013
1239
0.100
Why?
Disease Progression
2
2014
1053
0.100
Why?
Motivation
1
2014
270
0.100
Why?
Combat Disorders
1
2011
10
0.090
Why?
Patient Compliance
2
2014
373
0.090
Why?
Activities of Daily Living
2
2014
301
0.090
Why?
Life Change Events
1
2011
66
0.090
Why?
Internet
1
2014
465
0.090
Why?
Wounds and Injuries
1
2013
243
0.090
Why?
Amphetamine-Related Disorders
1
2009
12
0.080
Why?
Methamphetamine
1
2009
22
0.080
Why?
Chronic Disease
1
2013
744
0.080
Why?
Directive Counseling
1
2009
39
0.080
Why?
Benzhydryl Compounds
1
2009
48
0.080
Why?
Arkansas
1
2008
5
0.080
Why?
Cocaine
2
2025
87
0.080
Why?
Logistic Models
2
2011
1262
0.080
Why?
Secondary Prevention
1
2009
154
0.080
Why?
United States
3
2013
7622
0.080
Why?
Self Concept
1
2008
104
0.070
Why?
Paroxetine
2
2004
15
0.070
Why?
Middle Aged
6
2025
16542
0.070
Why?
Substance Withdrawal Syndrome
1
2008
119
0.070
Why?
Sex Characteristics
1
2008
198
0.070
Why?
Neuropsychological Tests
1
2008
353
0.070
Why?
Psychometrics
1
2008
359
0.070
Why?
Multivariate Analysis
1
2008
928
0.070
Why?
Mental Health Services
2
2011
300
0.060
Why?
Dysthymic Disorder
1
2005
8
0.060
Why?
Psychotherapy
1
2006
90
0.060
Why?
Mortality
1
2006
165
0.060
Why?
Pindolol
1
2004
2
0.060
Why?
Prolactin
1
2004
39
0.060
Why?
Antidepressive Agents
1
2006
230
0.060
Why?
Antidepressive Agents, Second-Generation
1
2004
28
0.060
Why?
Tryptophan
1
2004
55
0.060
Why?
Disability Evaluation
1
2005
217
0.060
Why?
Treatment Outcome
3
2025
5266
0.060
Why?
Combined Modality Therapy
2
2014
361
0.050
Why?
Adrenergic beta-Antagonists
1
2004
149
0.050
Why?
Cross-Sectional Studies
2
2011
2507
0.050
Why?
Hydrocortisone
1
2004
188
0.050
Why?
Commitment of Mentally Ill
1
2003
63
0.050
Why?
Drug Therapy, Combination
2
2014
436
0.050
Why?
Surveys and Questionnaires
1
2008
2615
0.040
Why?
Follow-Up Studies
1
2005
2360
0.040
Why?
Primary Health Care
1
2005
660
0.040
Why?
Adolescent
1
2009
5944
0.040
Why?
Remission Induction
2
2011
139
0.040
Why?
Diagnostic and Statistical Manual of Mental Disorders
2
2011
122
0.040
Why?
Retrospective Studies
1
2008
6147
0.030
Why?
GABA Agonists
1
2014
6
0.030
Why?
Diagnosis, Dual (Psychiatry)
1
2014
78
0.030
Why?
Cross-Over Studies
2
2004
144
0.030
Why?
Cholinesterase Inhibitors
1
2014
45
0.030
Why?
Residence Characteristics
1
2014
230
0.030
Why?
Recurrence
1
2014
600
0.020
Why?
Medication Adherence
1
2014
245
0.020
Why?
Caregivers
1
2014
232
0.020
Why?
Risk Factors
2
2011
5090
0.020
Why?
Analgesics, Opioid
1
2014
510
0.020
Why?
Self Report
1
2010
369
0.020
Why?
Alcohol Drinking
1
2010
305
0.020
Why?
Sex Factors
1
2011
971
0.020
Why?
Pilot Projects
1
2009
930
0.020
Why?
Mass Screening
1
2011
662
0.020
Why?
Fluoxetine
1
2004
44
0.010
Why?
Young Adult
1
2014
4398
0.010
Why?
Drug Administration Schedule
1
2004
281
0.010
Why?
Substance-Related Disorders
1
2011
691
0.010
Why?
Chopra's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (131)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_